Risperidone in the Treatment of Corticosteroid-Induced Mood Disorders, Manic/Mixed Episodes, in Systemic Lupus Erythematosus: A Case Series

• Published in: Psychosomatics (Washington, D.C.) Vol. 53; no. 3; pp. 289 - 293
• Main Authors: Nishimura, Katsuji, M.D., Ph.D, Omori, Masako, M.D, Sato, Eri, M.D, Katsumata, Yasuhiro, M.D., Ph.D, Gono, Takahisa, M.D., Ph.D, Kawaguchi, Yasushi, M.D., Ph.D, Harigai, Masayoshi, M.D., Ph.D, Yamanaka, Hisashi, M.D., Ph.D, Ishigooka, Jun, M.D., Ph.D
• Format: Journal Article
• Language: English
• Published: Arlington, VA Elsevier Inc 01.05.2012; American Psychiatric Publishing
• Subjects: Adrenal Cortex Hormones - administration & dosage; Adrenal Cortex Hormones - adverse effects; Adult; Adult and adolescent clinical studies; Antipsychotic Agents - therapeutic use; Biological and medical sciences; Drug Therapy, Combination; Female; Humans; Internal Medicine; Japan; Lupus Erythematosus, Systemic - drug therapy; Mania; Medical sciences; Middle Aged; Mood disorders; Mood Disorders - chemically induced; Mood Disorders - drug therapy; Neuropharmacology; Pharmacology. Drug treatments; Psychiatric Status Rating Scales; Psychiatry; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Risperidone - administration & dosage; Risperidone - adverse effects; Risperidone - therapeutic use; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Treatment Outcome; Young Adult; Japan; Mood disorder; Immunopathology; Connective tissue disease; Corticosteroid; Skin disease; Atypical antipsychotic; Neuroleptic; Psychotropic; Dopamine antagonist; Serotonin antagonist; Autoimmune disease; Serotonine receptor; D2 Dopamine receptor; Systemic lupus erythematosus; Treatment; Mixed episode; Systemic disease; Mania; Risperidone; Benzisoxazole derivatives
• ISSN: 0033-3182; 1545-7206
• DOI: 10.1016/j.psym.2011.08.010